Form 4 for BTSG BrightSpring Health Services, Inc.
Accepted 2024-01-30 00:00:00 ET · period of report 2023-11-21 · accession 0000950170-24-008829 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-01-30 | 2024-01-26 | BTSG | ROUSSEAU JON B | See Remarks, Dir | A - Grant | $0.00 | +967.9K | 969.8K | +49,712% | $0 |
| DM | 2024-01-30 | 2023-11-22+ | BTSG | ROUSSEAU JON B | See Remarks, Dir | A - Grant | $0.00 | +1.90M | 628.1K | New | $0 |
| DI | 2024-01-30 | 2023-11-21 | BTSG | ROUSSEAU JON B | See Remarks, Dir | D - Sale to Iss | $15.92 | -412.2K | 534.7K | -44% | -$6.56M |
| D | 2024-01-30 | 2023-11-21 | BTSG | ROUSSEAU JON B | See Remarks, Dir | D - Sale to Iss | $15.92 | -215.9K | 371.3K | -37% | -$3.44M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-01-26 | A | A | 967,884 | $0.00 | 969,831 | D | — | — | |
| 2 | Derivative | Stock Options (Right to Buy) | 2024-01-25 | A | A | 320,086 | $0.00 | 320,086 | D | $13.00 · — to 2034-01-25 | 320,086 Common Stock | (F8) Options granted on January 25, 2024 which vest in twelve equal quarterly installments commencing on April 25, 2024. Such securities were originally included on the Form 3 filed by the reporting person on January 26, 2024. |
| 3 | Derivative | Stock Options (Right to Buy) | 2024-01-25 | A | A | 955,823 | $0.00 | 1,327,081 | D | $6.37 · — to 2029-10-16 | 955,823 Common Stock | (F7) Options acquired represent options originally granted on October 16, 2019, which were previously subject to the achievement by the Issuer of performance vesting criteria and which were deemed vested on January 25, 2024, in connection with the pricing of the Issuer's initial public offering. Such securities were originally included on the Form 3 filed by the reporting person on January 26, 2024. The remaining 46,803 unvested options are subject to a time-based vesting schedule, which options shall fully vest on March 5, 2024. Reflects the Stock Split. Does not include unvested performance-based options which will be reported when earned upon achievement of certain performance criteria. |
| 4 | Derivative | Stock Options (Right to Buy) | 2023-11-21 | D | D | 412,195 | $15.92 | 534,676 | I | $6.37 · — to 2029-10-16 | 412,195 Common Stock | (F5) These options are fully vested. |
| 5 | Derivative | Stock Options (Right to Buy) | 2023-11-21 | D | D | 215,912 | $15.92 | 371,258 | D By The Margaret Rousseau Children Trust | $6.37 · — to 2029-10-16 | 215,912 Common Stock | (F3) Options granted on October 16, 2019, of which, the remaining 46,803 unvested options will vest fully on March 5, 2024. |
| 6 | Derivative | Stock Options (Right to Buy) | 2023-11-22 | A | A | 628,108 | $0.00 | 628,108 | D | $22.29 · — to 2033-11-22 | 628,108 Common Stock | (F6) Options acquired represent options originally granted on November 22, 2023 which vest one-third on May 22, 2024, and the remaining two-thirds to vest in equal monthly installments over the two years subsequent to the grant date. Such securities were originally included on the Form 3 filed by the reporting person on January 26, 2024. Reflects the Stock Split. |